FDA Inspection
Southern California Reproductive Center Medical Group PCSouthern California Reproductive Center Medical Group PC – FDA Inspection, Aug 15, 2022
Record Details
This FDA Inspection record concerns Southern California Reproductive Center Medical Group PC, with an inspection on August 15, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 15, 2022
- Product Type
- Biologics
View Company Profile
ID · af83341d-55d9-4412-83dc-6756d8a1769b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1178423
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Southern California Reproductive Center Medical Group PC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 8, 2025 | VAI | Los Angeles District Office | Human Cellular, Tissue, and Gene Therapies |
| August 24, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 6, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 17, 2011 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Southern California Reproductive Center Medical Group PC
- FDA Inspection 1275017 - 2025-07-08
- FDA Inspection 1027891 - 2017-08-24
- FDA Inspection 904200 - 2014-11-06
- FDA Inspection 732541 - 2011-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.